Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John G Lenehan

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Journal of the National Cancer Institute|January 12, 2021
Neoadjuvant Immunotherapy for High-Risk, Resectable Malignancies: Scientific Rationale and Clinical ChallengesMithunah Krishnamoorthy, John G Lenehan, Saman Maleki Vareki
Cancers|November 17, 2020
Immunomodulation in Pancreatic CancerMithunah Krishnamoorthy, John G Lenehan, Jeremy P Burton, et al.
Current Oncology (Toronto, Ont.)|March 24, 2022
Real-World Evidence of Systemic Therapy Sequencing on Overall Survival for Patients with Metastatic BRAF-Mutated Cutaneous MelanomaAdi Kartolo, Jasna Deluce, Wilma M Hopman, et al.
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|July 10, 2008
Women's knowledge, attitudes, and intentions concerning Human Papillomavirus vaccination: findings of a waiting room survey of obstetrics-gynaecology outpatientsJohn G Lenehan, Kevin C Leonard, Sukhjeen Nandra, et al.
Nature Medicine|January 28, 2026
Fecal microbiota transplantation plus immunotherapy in metastatic renal cell carcinoma: the phase 1 PERFORM trialRicardo Fernandes, Behnam Jabbarizadeh, Adnan Rajeh, et al.
Nature Medicine|July 6, 2023
Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trialBertrand Routy, John G Lenehan, Wilson H Miller, et al.
Nature Medicine|June 25, 2026
Metabolic determinants of cancer immunotherapy outcomes identified by plasma profilingDéborah Suissa, Marine Fidelle, Ella Reich, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Journal of the National Cancer Institute|January 12, 2021
Neoadjuvant Immunotherapy for High-Risk, Resectable Malignancies: Scientific Rationale and Clinical ChallengesMithunah Krishnamoorthy, John G Lenehan, Saman Maleki Vareki
Cancers|November 17, 2020
Immunomodulation in Pancreatic CancerMithunah Krishnamoorthy, John G Lenehan, Jeremy P Burton, et al.
Current Oncology (Toronto, Ont.)|March 24, 2022
Real-World Evidence of Systemic Therapy Sequencing on Overall Survival for Patients with Metastatic BRAF-Mutated Cutaneous MelanomaAdi Kartolo, Jasna Deluce, Wilma M Hopman, et al.
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|July 10, 2008
Women's knowledge, attitudes, and intentions concerning Human Papillomavirus vaccination: findings of a waiting room survey of obstetrics-gynaecology outpatientsJohn G Lenehan, Kevin C Leonard, Sukhjeen Nandra, et al.
Nature Medicine|January 28, 2026
Fecal microbiota transplantation plus immunotherapy in metastatic renal cell carcinoma: the phase 1 PERFORM trialRicardo Fernandes, Behnam Jabbarizadeh, Adnan Rajeh, et al.
Nature Medicine|July 6, 2023
Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trialBertrand Routy, John G Lenehan, Wilson H Miller, et al.
Nature Medicine|June 25, 2026
Metabolic determinants of cancer immunotherapy outcomes identified by plasma profilingDéborah Suissa, Marine Fidelle, Ella Reich, et al.
Pageof 1